Functional Genetics of Susceptibility to Prions
朊病毒易感性的功能遗传学
基本信息
- 批准号:6642188
- 负责人:
- 金额:$ 156.92万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2001
- 资助国家:美国
- 起止时间:2001-09-30 至 2006-07-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant) Prion diseases are
neurodegenerative disorders of humans and animals that involve misfolding of
prion protein (PrP). These diseases can present as genetic, infectious or
sporadic illnesses and each type is often transmissible to experimental
animals. Diseases caused by prions include scrapie, bovine spongiform
encephalopathy (BSE), and Creutzfeldt-Jakob disease (CJD) in humans. All prion
diseases involve changes in the conformation of PrP from its benign cellular
isoform, PrPC, to a disease-specific isoform, PrPsc. PrPsc is probably the sole
functional component of the infectious particle and different conformations of
PrPsc can encipher properties of prion strains. Originally thought to be
diseases caused by an exogenous slow virus, convincing evidence now indicates
that prion diseases are disorders of protein conformation. The discovery of a
new principle of infection resulted from research involving many disciplines
focused on PrP. The four senior investigators on this Program Project
application propose to extend their collaborative prion research efforts in a
new direction. Although PrP is central to infectivity, disease susceptibility
and pathogenesis, other molecules also are involved. Recent discoveries provide
the first opportunity to study mechanisms of prion replication and pathogenesis
by focusing on genes other than that encoding PrP. Treating scrapie incubation
time as a quantitative trait allowed the identification chromosomal regions
harboring prion incubation time modifier genes. These genes will be identified
using positional cloning and positional candidate approaches, aided by new
technologies in DNA analysis, expression microarrays and BAC engineering for
production of transgenic mice. Additional prion modifier genes will be
identified by sampling natural polymorphisms in mouse strains using QTL
analysis and by applying chemical mutagenesis to screen for novel prion
incubation time genes. The first gene encoding a PrP-related protein, Dpl, was
discovered downstream from the PrP gene. Although PrP and DpI exhibit only 25%
sequence identity, they share a conserved three-helix bundle structure. This
provides a unique opportunity to learn more about prion replication and disease
pathogenesis through creation of chimeric PrP:Dpl molecules. DpI misexpression
in brain causes cerebellar neurodegeneration that can be prevented by PrP
expression, suggesting involvement of similar pathways which will be
interrogated with cDNA arrays and by identification of modifier genes. In
addition to providing a new perspective on prion disease, these studies may
ultimately reveal pathways common to a variety of CNS degenerative disorders.
Prion疾病描述(由申请人提供)为
人类和动物的神经退行性疾病,涉及错误折叠
蛋白(PrP)。这些疾病可表现为遗传性、传染性或
散发性疾病和每种类型通常都会传播到实验中
动物。由普恩病毒引起的疾病包括瘙痒病、牛海绵状
人类的脑病(BSE)和克雅氏病(CJD)。全普赖恩
疾病涉及PrP从其良性细胞构象的变化
异构体PrPc到疾病特异性异构体PrPsc。PrPsc可能是唯一
感染性颗粒的功能成分和不同构象的
PrPsc可以对病毒株的特性进行加密。最初被认为是
由外源性慢病毒引起的疾病,现在有令人信服的证据表明
Pron病是蛋白质构象的紊乱。发现了一种
新的感染原理是多学科研究的结果
专注于PrP。该项目的四名高级调查人员
应用程序建议将他们的协作Prion研究工作扩展到
新方向。尽管PrP是传染性的核心,但疾病易感性
而发病机制中,其他分子也参与其中。最近的发现提供了
首次有机会研究病毒的复制机制和发病机制
通过关注编码PrP以外的基因。治疗瘙痒病孵化
时间作为数量性状允许识别染色体区域
含有Prion孵化时间修饰基因。这些基因将被识别出来
使用位置克隆和位置候选方法,由新的
DNA分析、表达微阵列和BAC工程技术
转基因小鼠的生产。更多的普恩修饰基因将是
利用QTL对小鼠品系的自然多态进行鉴定
化学诱变技术在筛选新蛋白中的应用
孵化时间基因。第一个编码PrP相关蛋白DPL的基因是
在PrP基因下游发现的。尽管PrP和DPI只显示了25%
序列同源性,它们共享一个保守的三螺旋束结构。这
提供了一个独特的机会来更多地了解Pron复制和疾病
通过产生嵌合PrP:DPL分子的发病机制。DPI错误表达
可通过PrP预防的小脑神经退行性变
表达,表明参与了类似的通路,将
用cDNA阵列和修饰基因的鉴定进行询问。在……里面
除了提供了一个新的视角来看待普里恩病,这些研究还可能
最终揭示了各种中枢神经系统退行性疾病的共同途径。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
George A. Carlson其他文献
Identification of three loci affecting HDL-cholesterol levels in a screen for chemically induced recessive mutations in mice
- DOI:
10.1194/jlr.m800471-jlr200 - 发表时间:
2009-03-01 - 期刊:
- 影响因子:
- 作者:
Todd Juan;Murielle M. Véniant;Joan Helmering;Philip Babij;Daniel M. Baker;Michael A. Damore;Michael B. Bass;Tibor Gyuris;Mark Chhoa;Chi-Ming Li;Chris Ebeling;Julie Amato;George A. Carlson;David J. Lloyd - 通讯作者:
David J. Lloyd
A welcoming environment for amyloid plaques
一个对淀粉样斑块有欢迎氛围的环境
- DOI:
10.1038/nn0403-328 - 发表时间:
2003-04-01 - 期刊:
- 影响因子:20.000
- 作者:
George A. Carlson - 通讯作者:
George A. Carlson
Generation of cytotoxic lymphocytes to syngeneic tumors by using co-stimulator (Interleukin 2): in vivo activity.
使用共刺激剂(白细胞介素 2)生成针对同基因肿瘤的细胞毒性淋巴细胞:体内活性。
- DOI:
- 发表时间:
1980 - 期刊:
- 影响因子:4.4
- 作者:
Gordon B. Mills;George A. Carlson;V. Paetkau - 通讯作者:
V. Paetkau
Allogeneic placenta is a paternal strain antigen immunoabsorbent.
同种异体胎盘是一种父本菌株抗原免疫吸收剂。
- DOI:
- 发表时间:
1979 - 期刊:
- 影响因子:4.4
- 作者:
Thomas G. Wegmann;Bhagirath Singh;George A. Carlson - 通讯作者:
George A. Carlson
Replication of multiple system atrophy prions in primary astrocyte cultures from transgenic mice expressing human α-synuclein
- DOI:
10.1186/s40478-019-0703-9 - 发表时间:
2019-05-20 - 期刊:
- 影响因子:5.700
- 作者:
Zuzana Krejciova;George A. Carlson;Kurt Giles;Stanley B. Prusiner - 通讯作者:
Stanley B. Prusiner
George A. Carlson的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('George A. Carlson', 18)}}的其他基金
CNS Stem Cells for neurodegenerative disease research
中枢神经系统干细胞用于神经退行性疾病研究
- 批准号:
8911231 - 财政年份:2014
- 资助金额:
$ 156.92万 - 项目类别:
CNS Stem Cells for neurodegenerative disease research
中枢神经系统干细胞用于神经退行性疾病研究
- 批准号:
8636329 - 财政年份:2014
- 资助金额:
$ 156.92万 - 项目类别:
CNS Stem Cells for Alzheimer's Disease Therapy
中枢神经系统干细胞用于治疗阿尔茨海默病
- 批准号:
6947776 - 财政年份:2004
- 资助金额:
$ 156.92万 - 项目类别:
CNS Stem Cells for Alzheimer's Disease Therapy
中枢神经系统干细胞用于治疗阿尔茨海默病
- 批准号:
6689433 - 财政年份:2004
- 资助金额:
$ 156.92万 - 项目类别:
24-Capillary Reveal Mutation Discovery System
24-毛细管揭示突变发现系统
- 批准号:
6578473 - 财政年份:2003
- 资助金额:
$ 156.92万 - 项目类别:
Functional Genetics of Susceptibility to Prions
朊病毒易感性的功能遗传学
- 批准号:
6801094 - 财政年份:2001
- 资助金额:
$ 156.92万 - 项目类别:
相似海外基金
STRUCTURAL BASIS OF PRION INFECTION: Tracking fluorescent prions to define their pathogenic pathways by cutting-edge light and electron microscopy
朊病毒感染的结构基础:通过尖端光学和电子显微镜追踪荧光朊病毒以定义其致病途径
- 批准号:
MR/X007332/1 - 财政年份:2023
- 资助金额:
$ 156.92万 - 项目类别:
Fellowship
Targeting the infectious potential of prions with DNA nanotechnology
利用 DNA 纳米技术瞄准朊病毒的感染潜力
- 批准号:
EP/X01729X/2 - 财政年份:2023
- 资助金额:
$ 156.92万 - 项目类别:
Research Grant
Structural diversity of cervid prions and phenotypic variation of chronic wasting disease
鹿朊病毒的结构多样性和慢性消耗性疾病的表型变异
- 批准号:
10657957 - 财政年份:2023
- 资助金额:
$ 156.92万 - 项目类别:
Role of heparan sulfate in neural cell vulnerability to prions
硫酸乙酰肝素在神经细胞对朊病毒的脆弱性中的作用
- 批准号:
10684301 - 财政年份:2022
- 资助金额:
$ 156.92万 - 项目类别:
Uptake of CWD prions by plant roots
植物根部对 CWD 朊病毒的吸收
- 批准号:
576917-2022 - 财政年份:2022
- 资助金额:
$ 156.92万 - 项目类别:
University Undergraduate Student Research Awards
Targeting the infectious potential of prions with DNA nanotechnology
利用 DNA 纳米技术瞄准朊病毒的感染潜力
- 批准号:
EP/X01729X/1 - 财政年份:2022
- 资助金额:
$ 156.92万 - 项目类别:
Research Grant
Role of heparan sulfate in neural cell vulnerability to prions
硫酸乙酰肝素在神经细胞对朊病毒的脆弱性中的作用
- 批准号:
10661885 - 财政年份:2022
- 资助金额:
$ 156.92万 - 项目类别:
Novel therapeutic strategies targeting malleability of wild-type and mutant prions
针对野生型和突变型朊病毒可塑性的新治疗策略
- 批准号:
10015750 - 财政年份:2020
- 资助金额:
$ 156.92万 - 项目类别:
Novel therapeutic strategies targeting malleability of wild-type and mutant prions
针对野生型和突变型朊病毒可塑性的新治疗策略
- 批准号:
10373098 - 财政年份:2020
- 资助金额:
$ 156.92万 - 项目类别:














{{item.name}}会员




